Free Delivery Over $100
|
|
|||
|
||||
OverviewDue to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products. Full Product DetailsAuthor: Isadore Kanfer , Leon Shargel , Leon Shargel , Leon ShargelPublisher: Taylor & Francis Ltd Imprint: CRC Press Weight: 0.453kg ISBN: 9780367384371ISBN 10: 036738437 Pages: 332 Publication Date: 05 September 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsIntroduction. Australasia. Brazil. Canada. The European Union. India. Japan. South Africa. South America and Pan American Health Organization. Taiwan. Turkey. United States of America. The World Health Organization.ReviewsAuthor InformationIsadore Kanfer, Leon Shargel Tab Content 6Author Website:Countries AvailableAll regions |
||||
